相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells
Ishani Banik et al.
PIGMENT CELL & MELANOMA RESEARCH (2021)
UV Radiation-induced Impairment of Cellular Morphology and Motility is Enhanced by DUSP3/VHR Loss and FAK Activation
Nadine Ranieri Pereira et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2021)
Nucleophosmin Protein Dephosphorylation by DUSP3 Is a Fine-Tuning Regulator of p53 Signaling to Maintain Genomic Stability
Lilian C. Russo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Inhibiting FAK-Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells
Antoine Mousson et al.
CANCERS (2021)
NRAS(Q61K) melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells
Ishani Banik et al.
PIGMENT CELL & MELANOMA RESEARCH (2021)
Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma
Judith Wenzina et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Mutation Signatures in Melanocytic Nevi Reveal Characteristics of Defective DNA Repair
Mitchell S. Stark et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation
Duen-Yi Huang et al.
CANCERS (2020)
DUSP3 maintains genomic stability and cell proliferation through modulation of the NER pathway and cell cycle regulatory proteins
Lilian Cristina Russo et al.
CELL CYCLE (2020)
Working on Genomic Stability: From the S-Phase to Mitosis
Sara Ovejero et al.
GENES (2020)
Regulation of signal transducer and activator of transcription 3 activation by dual-specificity phosphatase 3
Ba Reum Kim et al.
BMB REPORTS (2020)
FAK inhibition reduces metastasis of α4 integrin-expressing melanoma to lymph nodes by targeting lymphatic VCAM-1 expression
Kyuho Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Dual-Specificity Phosphatases in Immunity and Infection: An Update
Roland Lang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
STAT3 and STAT5 Activation in Solid Cancers
Sebastian Igelmann et al.
CANCERS (2019)
Targeting STAT3 and STAT5 in Tumor-Associated Immune Cells to Improve Immunotherapy
Gregory Verdeil et al.
CANCERS (2019)
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3
Ana Ruiz-Saenz et al.
CANCER RESEARCH (2018)
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
Giuseppe Palmieri et al.
CURRENT ONCOLOGY REPORTS (2018)
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine et al.
ONCOGENESIS (2018)
Paxillin: a crossroad in pathological cell migration
Ana Mara Lopez-Colome et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration
Y-R Chen et al.
ONCOGENE (2017)
MALT1 promotes melanoma progression through JNK/c-Jun signaling
Y. Wang et al.
ONCOGENESIS (2017)
Loss of DUSP3 activity radiosensitizes human tumor cell lines via attenuation of DNA repair pathways
Thompson E. P. Torres et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Nucleophosmin: from structure and function to disease development
Joseph K. Box et al.
BMC MOLECULAR BIOLOGY (2016)
Reduced levels of Dusp3/Vhr phosphatase impair normal spindle bipolarity in an Erk1/2 activity-dependent manner
Mahesh Balasaheb Tambe et al.
FEBS LETTERS (2016)
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation
Nan-Lin Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria
Hiroshi Mitsui et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Phosphorylated STAT5 regulates p53 expression via BRCA1/BARD1-NPM1 and MDM2
Zhuo Ren et al.
CELL DEATH & DISEASE (2016)
VHR/DUSP3 phosphatase: structure, function and regulation
Karolina Pavic et al.
FEBS JOURNAL (2015)
Combined experimental and bioinformatics analysis for the prediction and identification of VHR/DUSP3 nuclear targets related to DNA damage and repair
Fabio Luis Forti
INTEGRATIVE BIOLOGY (2015)
Genetics of melanocytic nevi
Mi Ryung Roh et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Understanding the Roles of FAK in Cancer: Inhibitors, Genetic Models, and New Insights
Hyunho Yoon et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2015)
VS-5584, a Novel PI3K-mTOR Dual Inhibitor, Inhibits Melanoma Cell Growth In Vitro and In Vivo
Zheren Shao et al.
PLOS ONE (2015)
Dual-Specificity Phosphatase 3 Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis
Lucia Musumeci et al.
CIRCULATION (2015)
DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase
Mathieu Amand et al.
MOLECULAR CANCER (2014)
Pathways and therapeutic targets in melanoma
Emma Shtivelman et al.
ONCOTARGET (2014)
The potential for targeting the STAT3 pathway as a novel therapy for melanoma
Gregory B. Lesinski
FUTURE ONCOLOGY (2013)
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Klaus W. Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma
Wesley O. Greaves et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Proteomic, Cellular, and Network Analyses Reveal New DUSP3 Interactions with Nucleolar Proteins in HeLa Cells
Karine Panico et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Changes of PI3K/AKT/BCL2 signaling proteins in congenital Giant Nevi: melanocytes contribute to their increased survival and integrity
Lior Drukker et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2013)
Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA
Sara Chiarella et al.
NUCLEIC ACIDS RESEARCH (2013)
Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
Christian Posch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The Role of the PI3K-AKT Pathway in Melanoma
Michael A. Davies
CANCER JOURNAL (2012)
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Liesbeth C. W. Vredeveld et al.
GENES & DEVELOPMENT (2012)
Identification of the Structural Features that Mediate Binding Specificity in the Recognition of STAT Proteins by Dual-Specificity Phosphatases
Christophe Jardin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2012)
NF-κB as potential target in the treatment of melanoma
Gabriele Madonna et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
The enigmatic role of nucleophosmin in malignant melanoma: Does it have an effect?
Aylin Orgen Calli et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2011)
Knockdown of NPM1 by RNA Interference Inhibits Cells Proliferation and Induces Apoptosis in Leukemic Cell Line
Feng-Xian Qin et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2011)
Vaccinia H1-related Phosphatase Is a Phosphatase of ErbB Receptors and Is Down-regulated in Non-small Cell Lung Cancer
Jiz-Yuh Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
p38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassembly
Payal Khanna et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
Tamara Terzian et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
Olivier Bailet et al.
CANCER RESEARCH (2009)
Nucleolin protein expression in cutaneous melanocytic lesions
Vasileios Mourmouras et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
Todd D. Prickett et al.
NATURE GENETICS (2009)
Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
Yeriel Estrada et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Protein kinase C α promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor
Hui Xu et al.
CARDIOVASCULAR RESEARCH (2008)
STAT3 as a biomarker of progression in atypical nevi of patients with melanoma:: Dose-response effects of systemic IFNα therapy
Wenjun Wang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
STAT5 contributes to antiapoptosis in melanoma
Jessica C. Hassel et al.
MELANOMA RESEARCH (2008)
JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis
Vasileia-Ismini Alexaki et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
High expression of DNA repair pathways is associated with metastasis in melanoma patients
A. Kauffmann et al.
ONCOGENE (2008)
Cutting edge: Selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase
Richard Hoyt et al.
JOURNAL OF IMMUNOLOGY (2007)
Rewired ERK-JNK signaling pathways in melanoma
Pablo Lopez-Bergami et al.
CANCER CELL (2007)
Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNα2b
Wenjun Wang et al.
CLINICAL CANCER RESEARCH (2007)
Modulation of oncogenic transcription and alternative splicing by β-catenin and an RNA aptamer in colon cancer cells
Hee Kyu Lee et al.
CANCER RESEARCH (2006)
Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma
Kjersti Jorgensen et al.
MODERN PATHOLOGY (2006)
Regulation of MAP kinases by the VHR dual-specific phosphatase - Implications for cell growth and differentiation
Fabio Cerignoli et al.
CELL CYCLE (2006)
Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase
Tae-Hong Kang et al.
NATURE CELL BIOLOGY (2006)
PI3-kinase subunits are infrequent somatic targets in melanoma
John A. Curtin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence
S Rahmouni et al.
NATURE CELL BIOLOGY (2006)
The role of protein kinase C δ activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation
M Gartsbein et al.
JOURNAL OF CELL SCIENCE (2006)
Focal adhesion kinase promotes the aggressive melanoma phenotype
AR Hess et al.
CANCER RESEARCH (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation
S Kurki et al.
CANCER CELL (2004)
Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland
J Steffen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells
A Ruschel et al.
CELLULAR SIGNALLING (2004)
Hypoxia-induced nucleophosmin protects cell death through inhibition of p53
J Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nucleophosmin sets a threshold for p53 response to UV radiation
DA Maiguel et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
PTEN signaling pathways in melanoma
H Wu et al.
ONCOGENE (2003)
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein
KC Corbit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
G Niu et al.
ONCOGENE (2002)
Nucleophosmin regulates the stability and transcriptional activity of p53
E Colombo et al.
NATURE CELL BIOLOGY (2002)
The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma
O Kahana et al.
ONCOGENE (2002)
Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage
E Selzer et al.
MELANOMA RESEARCH (2002)
Dual-specificity protein tyrosine phosphatase VHR down-regulates c-Jun N-terminal kinase (JNK)
JL Todd et al.
ONCOGENE (2002)
Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival
S Grant et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma
MT Landi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Recruitment of the class II phosphoinositide 3-kinase C2β to the epidermal growth factor receptor:: Role of Grb2
M Wheeler et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation
A Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression
VN Ivanov et al.
ONCOGENE (2000)
分享论文
